Thallinger, C., Lang, I., Kuhar, C. G., Bartsch, R., Singer, C. F., Petruzelka, L., . . . Zielinski, C. (2016). Phase II study on the efficacy and safety of Lapatinib administered beyond disease progression and combined with vinorelbine in HER-2/neu– positive advanced breast cancer: Results of the CECOG LaVie trial. BMC Cancer.
Trích dẫn kiểu ChicagoThallinger, Christiane, et al. "Phase II Study On the Efficacy and Safety of Lapatinib Administered Beyond Disease Progression and Combined With Vinorelbine in HER-2/neu– Positive Advanced Breast Cancer: Results of the CECOG LaVie Trial." BMC Cancer 2016.
Trích dẫn MLAThallinger, Christiane, et al. "Phase II Study On the Efficacy and Safety of Lapatinib Administered Beyond Disease Progression and Combined With Vinorelbine in HER-2/neu– Positive Advanced Breast Cancer: Results of the CECOG LaVie Trial." BMC Cancer 2016.